Results 161 to 170 of about 2,340,109 (293)

Systemic risk: Opportunities for inter- and transdisciplinary science to improve societal resilience. [PDF]

iScience
Sillmann J, Ciullo A, Franzke CLE, Scheffran J.   +3 more
europepmc   +1 more source

Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

Understand systemic risk from mangrove ecosystem through network analysis. [PDF]

Fundam Res
Gong M, Yu K, Huang Q, A Y, Aczel M, Li Y, Ran M, Cheng Y, Li K, Qu S.   +9 more
europepmc   +1 more source

Random fixed points, systemic risk and resilience of heterogeneous financial network. [PDF]

Ann Oper Res, 2022
Saha I, Kavitha V.
europepmc   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) Network investigators   +14 more
wiley   +1 more source

Incidence of surgical site infections in cerebrovascular surgery: systemic risk factors. [PDF]

Brain Spine
Messino V, Sigismondi S, Sergi PG, Ferrillo M, Bilotta F.   +4 more
europepmc   +1 more source

Intraocular lens dislocation: manifestation, ocular and systemic risk factors. [PDF]

Int Ophthalmol, 2023
Riedl JC, Rings S, Schuster AK, Vossmerbaeumer U.   +3 more
europepmc   +1 more source

Interoperability between central counterparties [PDF]

In reaction to recent requests for interoperability between central counterparties of European stock markets, regulators have issued new guidelines to contain systemic risk. Our analysis confirms that the currently applied cross-CCP risk management model
Jürg Mägerle, Thomas Nellen
core  

Role of Prednisone and 25‐Hydroxyvitamin D on Bone Mineral Density and Osteoporosis in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective We evaluated the role of 25‐hydroxyvitamin D (25[OH]D), prednisone, and other risk factors for bone mineral density (BMD) loss and osteoporosis in systemic lupus erythematosus (SLE). Methods We calculated the association between 25(OH)D levels and other potential risk factors and BMD measures (spine T scores) and osteoporosis (defined as a T ...
Nima Madanchi, Andrea Fava, Daniel W. Goldman, Laurence S. Magder, Michelle Petri   +4 more
wiley   +1 more source

Network centrality drives optimal protection investment against systemic risk propagation in complex systems. [PDF]

Sci Rep
Park C.
europepmc   +1 more source